Rhenium-188 Labeled Radiopharmaceuticals: Current Clinical Applications in Oncology and Promising Perspectives

Rhenium-188 Labeled Radiopharmaceuticals: Current Clinical Applications in Oncology and Promising Perspectives

Rhenium-188 (188Re) is a high energy beta-emitting radioisotope with a short 16.9 h physical half-life, which has been shown to be a very attractive candidate for use in therapeutic nuclear medicine. The high beta emission has an average energy of 784 keV and a maximum energy of 2.12 MeV, sufficient...

Full description

Bibliographic Details
Main Authors: Nicolas Lepareur, Franck Lacœuille, Christelle Bouvry, François Hindré, Emmanuel Garcion, Michel Chérel, Nicolas Noiret, Etienne Garin, F. F. Russ Knapp
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-06-01
Series:Frontiers in Medicine
Subjects:
bone pain palliation
oncology
peptides
radioembolization
radionuclide therapy
radiopharmaceuticals
Online Access:https://www.frontiersin.org/article/10.3389/fmed.2019.00132/full

Internet

https://www.frontiersin.org/article/10.3389/fmed.2019.00132/full

Similar Items